← Evidence map

ReviewMedChemComm2017

Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents.

Zaki S Seddigi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30108870